KennethHershonMD

PubMed

• 10 citations
  Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease
  Kenneth S. Hershon, Barbara R. Hirsch, Ola Odugbesan> ;Clinical Diabetes. 2019 Jul 1
• 11 citations
  Options for empagliflozin in combination therapy in type 2 diabetes mellitus.
  Kenneth S Hershon> ;International Journal of General Medicine. 2016 May 25
• 13 citations
  Mechanistic and clinical aspects of renin-angiotensin-aldosterone system blockade in the prevention of diabetes mellitus and cardiovascular disease.
  Kenneth S. Hershon> ;Endocrine Practice. 2011 May 1
• 187 citations
  Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes: Results of a 6-month, randomized, compara...
  Priscilla Hollander, Lawrence Blonde, Richard Rowe, Adi E. Mehta, Joseph L. Milburn, Kenneth S. Hershon, Jean Louis Chiasson, Seymour R. Levin> ;Diabetes Care. 2004 Oct 1
• 40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.
  Veitenhansl M, Stegner K, Hierl F, Dieterle C, Feldmeier H, Gutt B, Landgraf R, Garrow AP, Vileikyte L, Findlow A, Waterman C, Boulton AJM, Shankhdhar K, Shankhdhar L,...> ;Diabetologia. 2004-08-01
• 31 citations
  Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 diabetes.
  Kenneth S. Hershon, Thomas Blevins, Christy A. Mayo, Ralf Rosskamp> ;Endocrine Practice. 2004 Jan 1
• 37 citations
  Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia.
  Carola Saloranta, Kenneth Hershon, Michele Ball, Sheila Dickinson, David Holmes> ;The Journal of Clinical Endocrinology and Metabolism. 2002 Sep 1
• 4 citations
  PRIMARY, SECONDARY, TERTIARY, AND QUATERNARY TREATMENT WITH TROGLITAZONE IN TYPE 2 DIABETES MELLITUS IN AN OUTPATIENT CLINICAL PRACTICE
  Kenneth S. Hershon, Peter M. Hershon> ;Endocrine Practice. 2000 Jan 1
• 179 citations
  Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
  Barry I. Freedman, Jean-Paul Wuerth, Kenneth Cartwright, Raymond P. Bain, Stephen Dippe, Kenneth Hershon, Arshag D. Mooradian, Bruce Spinowitz> ;Controlled Clinical Trials. 1999 Oct 1
• 264 citations
  Use of Dermagraft, a Cultured Human Dermis, to Treat Diabetic Foot Ulcers
  Gary D Gentzkow, Scott D Iwasaki, Kenneth S. Hershon, Marvin Mengel, J Joseph Prendergast, John J Ricotta, David P Steed, Scott Lipkin> ;Diabetes Care. 1996 Apr 1
• 83 citations
  Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia
  Bo Angelin, Kenneth S. Hershon, John D. Brunzell> ;Proceedings of the National Academy of Sciences of the United States of America. 1987 Aug 1
• 21 citations
  Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1
  Kenneth S. Hershon, William A. Kelly, Cheng Mei Shaw, Robert S. Schwartz, Edwin L. Bierman> ;The American Journal of Medicine. 1983 Apr 1
• 4 citations
  Insulin Responses to Glucose in Non-insulin-dependent Diabetic Subjects With and Without the Chlorpropamide-Alcohol Flush: Effect of Salicylate and Naloxone
  Kenneth S. Hershon, Edwin L. Bierman, Carole M Bruzzone, John W. Ensinck> ;Diabetes Care. 1982 Jul 1
• Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naïve patients with type 2 diabetes: comparison with metformin.
  Göke, B., Hershon, K., Kerr, D., Calle Pascual, A., Schweizer, A., Foley, J., Shao, Q., Dejager, S.> ;Horm Metab Res. 2008 Dec
• Type II diabetes mellitus in Seattle and Tokyo.
  Fujimoto, W. Y., Hershon, K., Kinyoun, J., Stolov, W., Weinberg, C., Ishiwata, K., Kajinuma, H., Kanazawa, Y., Kuzuya, N.> ;Tohoku J Exp Med. 1983 Dec
• Removal of low density lipoproteins in sheep by extracorporeal affinity chromatography.
  Schmer, G., Rastelli, L., Dennis, M. B., Hershon, K., Young, J., Chait, A.> ;Trans Am Soc Artif Intern Organs. 1981
• Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
  Rosenstock, J., Einhorn, D., Hershon, K., Glazer, N. B., Yu, S.> ;Int J Clin Pract. 2002 May
• Join now to see all

Lectures

• Hot Topics in Internal Medicine - CME Getaways New York City 
  CME Getaways, New York, New York - 11/16/2012